<!DOCTYPE html>
<html lang="" xml:lang="">
<head>

  <meta charset="utf-8" />
  <meta http-equiv="X-UA-Compatible" content="IE=edge" />
  <title>30 Locally Advanced EsoCa | GI Surgical Oncology</title>
  <meta name="description" content="Orientation Manual for GI Surgical Oncology Service" />
  <meta name="generator" content="bookdown 0.34 and GitBook 2.6.7" />

  <meta property="og:title" content="30 Locally Advanced EsoCa | GI Surgical Oncology" />
  <meta property="og:type" content="book" />
  
  <meta property="og:description" content="Orientation Manual for GI Surgical Oncology Service" />
  

  <meta name="twitter:card" content="summary" />
  <meta name="twitter:title" content="30 Locally Advanced EsoCa | GI Surgical Oncology" />
  
  <meta name="twitter:description" content="Orientation Manual for GI Surgical Oncology Service" />
  




  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta name="apple-mobile-web-app-capable" content="yes" />
  <meta name="apple-mobile-web-app-status-bar-style" content="black" />
  <link rel="apple-touch-icon-precomposed" sizes="120x120" href="images/icon120.png" />
  <link rel="shortcut icon" href="images/favicon.io" type="image/x-icon" />
<link rel="prev" href="localized.html"/>
<link rel="next" href="eso_dcrt.html"/>
<script src="libs/jquery-3.6.0/jquery-3.6.0.min.js"></script>
<script src="https://cdn.jsdelivr.net/npm/fuse.js@6.4.6/dist/fuse.min.js"></script>
<link href="libs/gitbook-2.6.7/css/style.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-table.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-bookdown.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-highlight.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-search.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-fontsettings.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-clipboard.css" rel="stylesheet" />








<link href="libs/anchor-sections-1.1.0/anchor-sections.css" rel="stylesheet" />
<link href="libs/anchor-sections-1.1.0/anchor-sections-hash.css" rel="stylesheet" />
<script src="libs/anchor-sections-1.1.0/anchor-sections.js"></script>



<style type="text/css">
  
  div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
</style>
<style type="text/css">
/* Used with Pandoc 2.11+ new --citeproc when CSL is used */
div.csl-bib-body { }
div.csl-entry {
  clear: both;
}
.hanging div.csl-entry {
  margin-left:2em;
  text-indent:-2em;
}
div.csl-left-margin {
  min-width:2em;
  float:left;
}
div.csl-right-inline {
  margin-left:2em;
  padding-left:1em;
}
div.csl-indent {
  margin-left: 2em;
}
</style>

<link rel="stylesheet" href="style.css" type="text/css" />
</head>

<body>



  <div class="book without-animation with-summary font-size-2 font-family-1" data-basepath=".">

    <div class="book-summary">
      <nav role="navigation">

<ul class="summary">
<li>GI Surgical Oncology</li>

<li class="divider"></li>
<li class="chapter" data-level="1" data-path="index.html"><a href="index.html"><i class="fa fa-check"></i><b>1</b> Welcome</a></li>
<li class="chapter" data-level="2" data-path="Intro.html"><a href="Intro.html"><i class="fa fa-check"></i><b>2</b> Overview</a>
<ul>
<li class="chapter" data-level="2.1" data-path="Intro.html"><a href="Intro.html#absences"><i class="fa fa-check"></i><b>2.1</b> Absences</a></li>
<li class="chapter" data-level="2.2" data-path="Intro.html"><a href="Intro.html#communication"><i class="fa fa-check"></i><b>2.2</b> Communication</a></li>
<li class="chapter" data-level="2.3" data-path="Intro.html"><a href="Intro.html#medical-records"><i class="fa fa-check"></i><b>2.3</b> Medical Records</a></li>
<li class="chapter" data-level="2.4" data-path="Intro.html"><a href="Intro.html#operative-logs"><i class="fa fa-check"></i><b>2.4</b> Operative Logs</a></li>
<li class="chapter" data-level="2.5" data-path="Intro.html"><a href="Intro.html#case-assignment"><i class="fa fa-check"></i><b>2.5</b> Case Assignment</a></li>
<li class="chapter" data-level="2.6" data-path="Intro.html"><a href="Intro.html#clinic"><i class="fa fa-check"></i><b>2.6</b> Clinic</a></li>
<li class="chapter" data-level="2.7" data-path="Intro.html"><a href="Intro.html#work-hours"><i class="fa fa-check"></i><b>2.7</b> Work Hours</a></li>
</ul></li>
<li class="chapter" data-level="3" data-path="cmc-inpatient.html"><a href="cmc-inpatient.html"><i class="fa fa-check"></i><b>3</b> CMC Inpatient</a>
<ul>
<li class="chapter" data-level="3.1" data-path="cmc-inpatient.html"><a href="cmc-inpatient.html#admissions"><i class="fa fa-check"></i><b>3.1</b> Admissions</a></li>
<li class="chapter" data-level="3.2" data-path="cmc-inpatient.html"><a href="cmc-inpatient.html#rounds"><i class="fa fa-check"></i><b>3.2</b> Rounds</a></li>
<li class="chapter" data-level="3.3" data-path="cmc-inpatient.html"><a href="cmc-inpatient.html#resident-epic-teams"><i class="fa fa-check"></i><b>3.3</b> Resident Epic teams:</a></li>
<li class="chapter" data-level="3.4" data-path="cmc-inpatient.html"><a href="cmc-inpatient.html#consults"><i class="fa fa-check"></i><b>3.4</b> Consults</a></li>
<li class="chapter" data-level="3.5" data-path="cmc-inpatient.html"><a href="cmc-inpatient.html#postop-clinic-appt"><i class="fa fa-check"></i><b>3.5</b> Postop Clinic Appt</a></li>
<li class="chapter" data-level="3.6" data-path="cmc-inpatient.html"><a href="cmc-inpatient.html#conferences"><i class="fa fa-check"></i><b>3.6</b> Conferences</a></li>
</ul></li>
<li class="chapter" data-level="4" data-path="pineville-inpatient.html"><a href="pineville-inpatient.html"><i class="fa fa-check"></i><b>4</b> Pineville Inpatient</a>
<ul>
<li class="chapter" data-level="4.1" data-path="pineville-inpatient.html"><a href="pineville-inpatient.html#rounds-1"><i class="fa fa-check"></i><b>4.1</b> Rounds</a></li>
<li class="chapter" data-level="4.2" data-path="pineville-inpatient.html"><a href="pineville-inpatient.html#resident-epic-teams-1"><i class="fa fa-check"></i><b>4.2</b> Resident Epic teams:</a></li>
<li class="chapter" data-level="4.3" data-path="pineville-inpatient.html"><a href="pineville-inpatient.html#consults-1"><i class="fa fa-check"></i><b>4.3</b> Consults</a></li>
<li class="chapter" data-level="4.4" data-path="pineville-inpatient.html"><a href="pineville-inpatient.html#postop-clinic-appts"><i class="fa fa-check"></i><b>4.4</b> Postop Clinic Appts</a></li>
<li class="chapter" data-level="4.5" data-path="pineville-inpatient.html"><a href="pineville-inpatient.html#conferences-1"><i class="fa fa-check"></i><b>4.5</b> Conferences</a></li>
</ul></li>
<li class="chapter" data-level="5" data-path="rounds-2.html"><a href="rounds-2.html"><i class="fa fa-check"></i><b>5</b> Rounds</a></li>
<li class="chapter" data-level="6" data-path="progress-notes.html"><a href="progress-notes.html"><i class="fa fa-check"></i><b>6</b> Progress Notes</a></li>
<li class="chapter" data-level="7" data-path="discharges.html"><a href="discharges.html"><i class="fa fa-check"></i><b>7</b> Discharges</a></li>
<li class="chapter" data-level="8" data-path="education.html"><a href="education.html"><i class="fa fa-check"></i><b>8</b> Education</a>
<ul>
<li class="chapter" data-level="8.1" data-path="education.html"><a href="education.html#proceduresdiseases"><i class="fa fa-check"></i><b>8.1</b> Procedures/Diseases</a></li>
<li class="chapter" data-level="8.2" data-path="education.html"><a href="education.html#ask-a-resident-5min-discussion"><i class="fa fa-check"></i><b>8.2</b> Ask a Resident (5min discussion)</a></li>
<li class="chapter" data-level="8.3" data-path="education.html"><a href="education.html#medical-student-resources"><i class="fa fa-check"></i><b>8.3</b> Medical Student Resources</a></li>
</ul></li>
<li class="chapter" data-level="9" data-path="clinic-1.html"><a href="clinic-1.html"><i class="fa fa-check"></i><b>9</b> Clinic</a>
<ul>
<li class="chapter" data-level="9.1" data-path="clinic-1.html"><a href="clinic-1.html#salo-clinic"><i class="fa fa-check"></i><b>9.1</b> Salo Clinic</a></li>
</ul></li>
<li class="chapter" data-level="10" data-path="mie_postop.html"><a href="mie_postop.html"><i class="fa fa-check"></i><b>10</b> Postop Care after Esophagectomy</a>
<ul>
<li class="chapter" data-level="10.1" data-path="mie_postop.html"><a href="mie_postop.html#weaning-tube-feeds-in-diabetics"><i class="fa fa-check"></i><b>10.1</b> Weaning Tube Feeds in Diabetics</a></li>
</ul></li>
<li class="part"><span><b>Postoperative Care</b></span></li>
<li class="chapter" data-level="11" data-path="colectomy.html"><a href="colectomy.html"><i class="fa fa-check"></i><b>11</b> Colectomy</a></li>
<li class="chapter" data-level="12" data-path="lar-ileostomy.html"><a href="lar-ileostomy.html"><i class="fa fa-check"></i><b>12</b> LAR + Ileostomy</a></li>
<li class="chapter" data-level="13" data-path="abdominoperineal-resection.html"><a href="abdominoperineal-resection.html"><i class="fa fa-check"></i><b>13</b> Abdominoperineal Resection</a></li>
<li class="chapter" data-level="14" data-path="esophagectomy-postop.html"><a href="esophagectomy-postop.html"><i class="fa fa-check"></i><b>14</b> Esophagectomy Postop</a></li>
<li class="chapter" data-level="15" data-path="esophagectomy-ward.html"><a href="esophagectomy-ward.html"><i class="fa fa-check"></i><b>15</b> Esophagectomy Ward</a>
<ul>
<li class="chapter" data-level="15.1" data-path="esophagectomy-ward.html"><a href="esophagectomy-ward.html#anti-hypertensives"><i class="fa fa-check"></i><b>15.1</b> Anti-Hypertensives</a></li>
<li class="chapter" data-level="15.2" data-path="esophagectomy-ward.html"><a href="esophagectomy-ward.html#chest-tubes"><i class="fa fa-check"></i><b>15.2</b> Chest tubes</a></li>
<li class="chapter" data-level="15.3" data-path="esophagectomy-ward.html"><a href="esophagectomy-ward.html#gi-medicines"><i class="fa fa-check"></i><b>15.3</b> GI Medicines</a></li>
<li class="chapter" data-level="15.4" data-path="esophagectomy-ward.html"><a href="esophagectomy-ward.html#leak_evaluation"><i class="fa fa-check"></i><b>15.4</b> Evaluation for leak</a>
<ul>
<li class="chapter" data-level="15.4.1" data-path="esophagectomy-ward.html"><a href="esophagectomy-ward.html#drain_amylase"><i class="fa fa-check"></i><b>15.4.1</b> Drain Amylase</a></li>
<li class="chapter" data-level="15.4.2" data-path="esophagectomy-ward.html"><a href="esophagectomy-ward.html#ct_esophagram"><i class="fa fa-check"></i><b>15.4.2</b> CT esophagram</a></li>
</ul></li>
<li class="chapter" data-level="15.5" data-path="esophagectomy-ward.html"><a href="esophagectomy-ward.html#anastomotic-leak-treatment"><i class="fa fa-check"></i><b>15.5</b> Anastomotic Leak Treatment</a>
<ul>
<li class="chapter" data-level="15.5.1" data-path="esophagectomy-ward.html"><a href="esophagectomy-ward.html#labs"><i class="fa fa-check"></i><b>15.5.1</b> Labs</a></li>
<li class="chapter" data-level="15.5.2" data-path="esophagectomy-ward.html"><a href="esophagectomy-ward.html#discharge-medicines"><i class="fa fa-check"></i><b>15.5.2</b> Discharge Medicines</a></li>
<li class="chapter" data-level="15.5.3" data-path="esophagectomy-ward.html"><a href="esophagectomy-ward.html#diet-at-discharge"><i class="fa fa-check"></i><b>15.5.3</b> Diet at discharge</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="16" data-path="jejunostomy-feedings.html"><a href="jejunostomy-feedings.html"><i class="fa fa-check"></i><b>16</b> Jejunostomy Feedings</a>
<ul>
<li class="chapter" data-level="16.1" data-path="jejunostomy-feedings.html"><a href="jejunostomy-feedings.html#med-administration-via-j-tubes"><i class="fa fa-check"></i><b>16.1</b> Med Administration via J-Tubes</a></li>
<li class="chapter" data-level="16.2" data-path="jejunostomy-feedings.html"><a href="jejunostomy-feedings.html#occluded-jejunostomy-tubes"><i class="fa fa-check"></i><b>16.2</b> Occluded Jejunostomy Tubes</a></li>
<li class="chapter" data-level="16.3" data-path="jejunostomy-feedings.html"><a href="jejunostomy-feedings.html#jejunostomy-feedings-on-preop-patients"><i class="fa fa-check"></i><b>16.3</b> Jejunostomy feedings on preop Patients</a></li>
<li class="chapter" data-level="16.4" data-path="jejunostomy-feedings.html"><a href="jejunostomy-feedings.html#jejunostomy_diabetes"><i class="fa fa-check"></i><b>16.4</b> Jejunostomy + Diabetes</a></li>
</ul></li>
<li class="chapter" data-level="17" data-path="gastrostomy-feeds.html"><a href="gastrostomy-feeds.html"><i class="fa fa-check"></i><b>17</b> Gastrostomy Feeds</a>
<ul>
<li class="chapter" data-level="17.1" data-path="gastrostomy-feeds.html"><a href="gastrostomy-feeds.html#free-water-flushes"><i class="fa fa-check"></i><b>17.1</b> Free Water Flushes</a></li>
<li class="chapter" data-level="17.2" data-path="gastrostomy-feeds.html"><a href="gastrostomy-feeds.html#med-administration-via-g-tubes"><i class="fa fa-check"></i><b>17.2</b> Med Administration via G-Tubes</a></li>
</ul></li>
<li class="part"><span><b>Hill OR</b></span></li>
<li class="chapter" data-level="18" data-path="colorectal-cases---hillsquires.html"><a href="colorectal-cases---hillsquires.html"><i class="fa fa-check"></i><b>18</b> Colorectal Cases - Hill/Squires</a></li>
<li class="part"><span><b>Salo OR</b></span></li>
<li class="chapter" data-level="19" data-path="cv_port_salo.html"><a href="cv_port_salo.html"><i class="fa fa-check"></i><b>19</b> CV Port (IJ)</a></li>
<li class="chapter" data-level="20" data-path="lap-jejunostomy.html"><a href="lap-jejunostomy.html"><i class="fa fa-check"></i><b>20</b> Lap Jejunostomy</a></li>
<li class="chapter" data-level="21" data-path="lap_gastrostomy_salo.html"><a href="lap_gastrostomy_salo.html"><i class="fa fa-check"></i><b>21</b> Lap Gastrostomy</a></li>
<li class="chapter" data-level="22" data-path="esophagectomy-1-stage.html"><a href="esophagectomy-1-stage.html"><i class="fa fa-check"></i><b>22</b> Esophagectomy 1 Stage</a>
<ul>
<li class="chapter" data-level="22.1" data-path="esophagectomy-1-stage.html"><a href="esophagectomy-1-stage.html#indications"><i class="fa fa-check"></i><b>22.1</b> Indications</a></li>
<li class="chapter" data-level="22.2" data-path="esophagectomy-1-stage.html"><a href="esophagectomy-1-stage.html#room-prep"><i class="fa fa-check"></i><b>22.2</b> Room Prep</a></li>
<li class="chapter" data-level="22.3" data-path="esophagectomy-1-stage.html"><a href="esophagectomy-1-stage.html#position"><i class="fa fa-check"></i><b>22.3</b> Position</a>
<ul>
<li class="chapter" data-level="22.3.1" data-path="esophagectomy-1-stage.html"><a href="esophagectomy-1-stage.html#time-out"><i class="fa fa-check"></i><b>22.3.1</b> Time Out</a></li>
</ul></li>
<li class="chapter" data-level="22.4" data-path="esophagectomy-1-stage.html"><a href="esophagectomy-1-stage.html#gastric-mobilization"><i class="fa fa-check"></i><b>22.4</b> Gastric Mobilization</a>
<ul>
<li class="chapter" data-level="22.4.1" data-path="esophagectomy-1-stage.html"><a href="esophagectomy-1-stage.html#distal-mobilization"><i class="fa fa-check"></i><b>22.4.1</b> Distal mobilization</a></li>
<li class="chapter" data-level="22.4.2" data-path="esophagectomy-1-stage.html"><a href="esophagectomy-1-stage.html#left-gastric-artery"><i class="fa fa-check"></i><b>22.4.2</b> Left gastric artery</a></li>
<li class="chapter" data-level="22.4.3" data-path="esophagectomy-1-stage.html"><a href="esophagectomy-1-stage.html#mediastinal-dissection"><i class="fa fa-check"></i><b>22.4.3</b> Mediastinal dissection</a></li>
<li class="chapter" data-level="22.4.4" data-path="esophagectomy-1-stage.html"><a href="esophagectomy-1-stage.html#division-of-esophagus-four-phase"><i class="fa fa-check"></i><b>22.4.4</b> Division of Esophagus (Four-Phase)</a></li>
<li class="chapter" data-level="22.4.5" data-path="esophagectomy-1-stage.html"><a href="esophagectomy-1-stage.html#entry-into-right-chest"><i class="fa fa-check"></i><b>22.4.5</b> Entry into right chest</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="23" data-path="node_salo.html"><a href="node_salo.html"><i class="fa fa-check"></i><b>23</b> Lymph Node Bioppsy</a></li>
<li class="part"><span><b>Esophageal Cancer</b></span></li>
<li class="chapter" data-level="24" data-path="EsoObjJB.html"><a href="EsoObjJB.html"><i class="fa fa-check"></i><b>24</b> EsoCa SCORE - JR</a></li>
<li class="chapter" data-level="25" data-path="EsoObjCR.html"><a href="EsoObjCR.html"><i class="fa fa-check"></i><b>25</b> EsoCa Objectives - Chief</a></li>
<li class="chapter" data-level="26" data-path="EsoIntro.html"><a href="EsoIntro.html"><i class="fa fa-check"></i><b>26</b> Esophageal Overview</a></li>
<li class="chapter" data-level="27" data-path="staging.html"><a href="staging.html"><i class="fa fa-check"></i><b>27</b> Staging</a></li>
<li class="chapter" data-level="28" data-path="superficial.html"><a href="superficial.html"><i class="fa fa-check"></i><b>28</b> Superficial EsoCa</a>
<ul>
<li class="chapter" data-level="28.1" data-path="superficial.html"><a href="superficial.html#emr"><i class="fa fa-check"></i><b>28.1</b> Endscopic Mucosal Resection (EMR)</a></li>
</ul></li>
<li class="chapter" data-level="29" data-path="localized.html"><a href="localized.html"><i class="fa fa-check"></i><b>29</b> Localized EsoCa</a>
<ul>
<li class="chapter" data-level="29.1" data-path="localized.html"><a href="localized.html#t1b-tumors"><i class="fa fa-check"></i><b>29.1</b> T1b Tumors</a></li>
<li class="chapter" data-level="29.2" data-path="localized.html"><a href="localized.html#t2n0-tumors"><i class="fa fa-check"></i><b>29.2</b> T2N0 Tumors</a></li>
<li class="chapter" data-level="29.3" data-path="localized.html"><a href="localized.html#staging-of-t2n0-tumors"><i class="fa fa-check"></i><b>29.3</b> Staging of T2N0 Tumors</a></li>
</ul></li>
<li class="chapter" data-level="30" data-path="locally_advanced.html"><a href="locally_advanced.html"><i class="fa fa-check"></i><b>30</b> Locally Advanced EsoCa</a>
<ul>
<li class="chapter" data-level="30.1" data-path="locally_advanced.html"><a href="locally_advanced.html#trimodality"><i class="fa fa-check"></i><b>30.1</b> Trimodality Therapy</a>
<ul>
<li class="chapter" data-level="30.1.1" data-path="locally_advanced.html"><a href="locally_advanced.html#neoadjuvant-chemort-for-scca"><i class="fa fa-check"></i><b>30.1.1</b> Neoadjuvant chemoRT for SCCA</a></li>
<li class="chapter" data-level="30.1.2" data-path="locally_advanced.html"><a href="locally_advanced.html#neoadjuvant-chemotheraphy-followed-by-surgery"><i class="fa fa-check"></i><b>30.1.2</b> Neoadjuvant chemotheraphy followed by surgery</a></li>
</ul></li>
<li class="chapter" data-level="30.2" data-path="locally_advanced.html"><a href="locally_advanced.html#ge-junction"><i class="fa fa-check"></i><b>30.2</b> GE Junction</a></li>
<li class="chapter" data-level="30.3" data-path="locally_advanced.html"><a href="locally_advanced.html#induction-chemotherapy-followed-by-chemort"><i class="fa fa-check"></i><b>30.3</b> Induction chemotherapy followed by chemoRT</a></li>
<li class="chapter" data-level="30.4" data-path="locally_advanced.html"><a href="locally_advanced.html#postoperative-chemoradiation"><i class="fa fa-check"></i><b>30.4</b> Postoperative chemoradiation</a></li>
</ul></li>
<li class="chapter" data-level="31" data-path="eso_dcrt.html"><a href="eso_dcrt.html"><i class="fa fa-check"></i><b>31</b> Chemoradiation</a>
<ul>
<li class="chapter" data-level="31.1" data-path="eso_dcrt.html"><a href="eso_dcrt.html#phase-ii-studies"><i class="fa fa-check"></i><b>31.1</b> Phase II Studies</a></li>
<li class="chapter" data-level="31.2" data-path="eso_dcrt.html"><a href="eso_dcrt.html#chemort-vs-trimodality-therapy"><i class="fa fa-check"></i><b>31.2</b> ChemoRT vs Trimodality therapy</a></li>
</ul></li>
<li class="chapter" data-level="32" data-path="radiation.html"><a href="radiation.html"><i class="fa fa-check"></i><b>32</b> Radiation</a></li>
<li class="chapter" data-level="33" data-path="esophagectomy.html"><a href="esophagectomy.html"><i class="fa fa-check"></i><b>33</b> Esophagectomy</a>
<ul>
<li class="chapter" data-level="33.0.1" data-path="esophagectomy.html"><a href="esophagectomy.html#ge-junction-adenocarcinoma"><i class="fa fa-check"></i><b>33.0.1</b> GE Junction Adenocarcinoma</a></li>
<li class="chapter" data-level="33.0.2" data-path="esophagectomy.html"><a href="esophagectomy.html#preoperative-evaluation"><i class="fa fa-check"></i><b>33.0.2</b> Preoperative Evaluation</a></li>
<li class="chapter" data-level="33.1" data-path="esophagectomy.html"><a href="esophagectomy.html#minimally-invasive-esophagectomy"><i class="fa fa-check"></i><b>33.1</b> Minimally-invasive Esophagectomy</a></li>
<li class="chapter" data-level="33.2" data-path="esophagectomy.html"><a href="esophagectomy.html#early-recovery-pathways"><i class="fa fa-check"></i><b>33.2</b> Early Recovery Pathways</a></li>
<li class="chapter" data-level="33.3" data-path="esophagectomy.html"><a href="esophagectomy.html#salvage-esophagectomy"><i class="fa fa-check"></i><b>33.3</b> Salvage esophagectomy</a></li>
</ul></li>
<li class="chapter" data-level="34" data-path="eso_metastatic.html"><a href="eso_metastatic.html"><i class="fa fa-check"></i><b>34</b> Metastatic EsoCa</a>
<ul>
<li class="chapter" data-level="34.1" data-path="eso_metastatic.html"><a href="eso_metastatic.html#palliative-radiation"><i class="fa fa-check"></i><b>34.1</b> Palliative radiation</a></li>
<li class="chapter" data-level="34.2" data-path="eso_metastatic.html"><a href="eso_metastatic.html#chemoradiation-vs-chemotherapy-in-stage-iv"><i class="fa fa-check"></i><b>34.2</b> Chemoradiation vs chemotherapy in Stage IV</a></li>
<li class="chapter" data-level="34.3" data-path="eso_metastatic.html"><a href="eso_metastatic.html#stents-for-malignant-disease"><i class="fa fa-check"></i><b>34.3</b> Stents for malignant disease</a></li>
</ul></li>
<li class="chapter" data-level="35" data-path="eso_survivorship.html"><a href="eso_survivorship.html"><i class="fa fa-check"></i><b>35</b> Survivorship</a>
<ul>
<li class="chapter" data-level="35.1" data-path="eso_survivorship.html"><a href="eso_survivorship.html#nutritional-consequences-of-esophagectomy"><i class="fa fa-check"></i><b>35.1</b> Nutritional consequences of esophagectomy</a>
<ul>
<li class="chapter" data-level="35.1.1" data-path="eso_survivorship.html"><a href="eso_survivorship.html#vitamin-d-deficiency"><i class="fa fa-check"></i><b>35.1.1</b> Vitamin D deficiency</a></li>
</ul></li>
<li class="chapter" data-level="35.2" data-path="eso_survivorship.html"><a href="eso_survivorship.html#cardiac-toxicity-of-radiation"><i class="fa fa-check"></i><b>35.2</b> Cardiac toxicity of radiation</a></li>
<li class="chapter" data-level="35.3" data-path="eso_survivorship.html"><a href="eso_survivorship.html#eso_surveillance"><i class="fa fa-check"></i><b>35.3</b> Surveillance</a></li>
</ul></li>
<li class="part"><span><b>Gastric Cancer</b></span></li>
<li class="chapter" data-level="36" data-path="gastric-ca-score.html"><a href="gastric-ca-score.html"><i class="fa fa-check"></i><b>36</b> Gastric Ca SCORE</a></li>
<li class="chapter" data-level="37" data-path="gast_superficial.html"><a href="gast_superficial.html"><i class="fa fa-check"></i><b>37</b> Superficial Gastric</a></li>
<li class="chapter" data-level="38" data-path="locally-advanced-gastric.html"><a href="locally-advanced-gastric.html"><i class="fa fa-check"></i><b>38</b> Locally-Advanced Gastric</a>
<ul>
<li class="chapter" data-level="38.1" data-path="locally-advanced-gastric.html"><a href="locally-advanced-gastric.html#preoperative-chemotherapy"><i class="fa fa-check"></i><b>38.1</b> Preoperative Chemotherapy</a></li>
<li class="chapter" data-level="38.2" data-path="locally-advanced-gastric.html"><a href="locally-advanced-gastric.html#postoperative-chemotherapy"><i class="fa fa-check"></i><b>38.2</b> Postoperative chemotherapy</a></li>
<li class="chapter" data-level="38.3" data-path="locally-advanced-gastric.html"><a href="locally-advanced-gastric.html#postoperative-chemoradiation-1"><i class="fa fa-check"></i><b>38.3</b> Postoperative chemoradiation</a></li>
<li class="chapter" data-level="38.4" data-path="locally-advanced-gastric.html"><a href="locally-advanced-gastric.html#preoperative-chemoradiation"><i class="fa fa-check"></i><b>38.4</b> Preoperative chemoradiation</a></li>
</ul></li>
<li class="chapter" data-level="39" data-path="hereditary-diffuse-gastric-cancer.html"><a href="hereditary-diffuse-gastric-cancer.html"><i class="fa fa-check"></i><b>39</b> Hereditary Diffuse Gastric Cancer</a></li>
<li class="chapter" data-level="40" data-path="gastrectomy.html"><a href="gastrectomy.html"><i class="fa fa-check"></i><b>40</b> Gastrectomy</a>
<ul>
<li class="chapter" data-level="40.1" data-path="gastrectomy.html"><a href="gastrectomy.html#proximal-gastrectomy"><i class="fa fa-check"></i><b>40.1</b> Proximal gastrectomy</a></li>
</ul></li>
<li class="chapter" data-level="41" data-path="gastric-gist.html"><a href="gastric-gist.html"><i class="fa fa-check"></i><b>41</b> Gastric GIST</a>
<ul>
<li class="chapter" data-level="41.1" data-path="gastric-gist.html"><a href="gastric-gist.html#genetics"><i class="fa fa-check"></i><b>41.1</b> Genetics</a></li>
</ul></li>
<li class="part"><span><b>Colon Cancer</b></span></li>
<li class="chapter" data-level="42" data-path="ColonObjCR.html"><a href="ColonObjCR.html"><i class="fa fa-check"></i><b>42</b> ColonCa SCORE</a></li>
<li class="chapter" data-level="43" data-path="ColonGenetics.html"><a href="ColonGenetics.html"><i class="fa fa-check"></i><b>43</b> ColonCa Genetics</a></li>
<li class="chapter" data-level="44" data-path="PColectomyObj.html"><a href="PColectomyObj.html"><i class="fa fa-check"></i><b>44</b> Partial Colectomy SCORE</a></li>
<li class="chapter" data-level="45" data-path="ColostomyObj.html"><a href="ColostomyObj.html"><i class="fa fa-check"></i><b>45</b> Colostomy SCORE</a></li>
<li class="chapter" data-level="46" data-path="TColectomyObj.html"><a href="TColectomyObj.html"><i class="fa fa-check"></i><b>46</b> Total Colectomy SCORE</a></li>
<li class="chapter" data-level="47" data-path="stage-iv-colon-cancer.html"><a href="stage-iv-colon-cancer.html"><i class="fa fa-check"></i><b>47</b> Stage IV Colon Cancer</a>
<ul>
<li class="chapter" data-level="47.1" data-path="stage-iv-colon-cancer.html"><a href="stage-iv-colon-cancer.html#stent-vs-colostomy"><i class="fa fa-check"></i><b>47.1</b> Stent vs colostomy</a></li>
<li class="chapter" data-level="47.2" data-path="stage-iv-colon-cancer.html"><a href="stage-iv-colon-cancer.html#colon-resection-in-stage-iv-colon-cancer"><i class="fa fa-check"></i><b>47.2</b> Colon resection in stage IV colon cancer</a></li>
<li class="chapter" data-level="47.3" data-path="stage-iv-colon-cancer.html"><a href="stage-iv-colon-cancer.html#immunotherapy-for-dmmr-msi-high"><i class="fa fa-check"></i><b>47.3</b> Immunotherapy for dMMR (MSI high)</a></li>
<li class="chapter" data-level="47.4" data-path="stage-iv-colon-cancer.html"><a href="stage-iv-colon-cancer.html#peritoneal-colon-cancer"><i class="fa fa-check"></i><b>47.4</b> Peritoneal Colon Cancer</a></li>
</ul></li>
<li class="chapter" data-level="48" data-path="colectomy-1.html"><a href="colectomy-1.html"><i class="fa fa-check"></i><b>48</b> Colectomy</a>
<ul>
<li class="chapter" data-level="48.1" data-path="colectomy-1.html"><a href="colectomy-1.html#extended-node-dissection"><i class="fa fa-check"></i><b>48.1</b> Extended Node dissection</a></li>
</ul></li>
<li class="chapter" data-level="49" data-path="chemotherapy.html"><a href="chemotherapy.html"><i class="fa fa-check"></i><b>49</b> Chemotherapy</a>
<ul>
<li class="chapter" data-level="49.1" data-path="chemotherapy.html"><a href="chemotherapy.html#neoadjuvant-chemotherapy"><i class="fa fa-check"></i><b>49.1</b> Neoadjuvant Chemotherapy</a></li>
</ul></li>
<li class="chapter" data-level="50" data-path="appendiceal-ca.html"><a href="appendiceal-ca.html"><i class="fa fa-check"></i><b>50</b> Appendiceal Ca</a>
<ul>
<li class="chapter" data-level="50.1" data-path="appendiceal-ca.html"><a href="appendiceal-ca.html#categories"><i class="fa fa-check"></i><b>50.1</b> Categories:</a></li>
</ul></li>
<li class="part"><span><b>Rectal Cancer</b></span></li>
<li class="chapter" data-level="51" data-path="rectalca-score.html"><a href="rectalca-score.html"><i class="fa fa-check"></i><b>51</b> RectalCa SCORE</a>
<ul>
<li class="chapter" data-level="51.1" data-path="rectalca-score.html"><a href="rectalca-score.html#anatomy"><i class="fa fa-check"></i><b>51.1</b> Anatomy</a></li>
<li class="chapter" data-level="51.2" data-path="rectalca-score.html"><a href="rectalca-score.html#presentation"><i class="fa fa-check"></i><b>51.2</b> Presentation</a></li>
<li class="chapter" data-level="51.3" data-path="rectalca-score.html"><a href="rectalca-score.html#operative-tx"><i class="fa fa-check"></i><b>51.3</b> Operative Tx</a>
<ul>
<li class="chapter" data-level="51.3.1" data-path="rectalca-score.html"><a href="rectalca-score.html#total-mesorectal-excision"><i class="fa fa-check"></i><b>51.3.1</b> Total mesorectal excision</a></li>
<li class="chapter" data-level="51.3.2" data-path="rectalca-score.html"><a href="rectalca-score.html#transanal-excision"><i class="fa fa-check"></i><b>51.3.2</b> Transanal excision</a></li>
<li class="chapter" data-level="51.3.3" data-path="rectalca-score.html"><a href="rectalca-score.html#isolated-liver-mets"><i class="fa fa-check"></i><b>51.3.3</b> Isolated liver mets</a></li>
</ul></li>
<li class="chapter" data-level="51.4" data-path="rectalca-score.html"><a href="rectalca-score.html#adjuvant-therapy"><i class="fa fa-check"></i><b>51.4</b> Adjuvant therapy</a></li>
</ul></li>
<li class="chapter" data-level="52" data-path="objectives---aprexent.html"><a href="objectives---aprexent.html"><i class="fa fa-check"></i><b>52</b> Objectives - APR/Exent</a>
<ul>
<li class="chapter" data-level="52.1" data-path="objectives---aprexent.html"><a href="objectives---aprexent.html#indications-1"><i class="fa fa-check"></i><b>52.1</b> Indications</a></li>
<li class="chapter" data-level="52.2" data-path="objectives---aprexent.html"><a href="objectives---aprexent.html#operative-anatomy"><i class="fa fa-check"></i><b>52.2</b> Operative Anatomy</a></li>
<li class="chapter" data-level="52.3" data-path="objectives---aprexent.html"><a href="objectives---aprexent.html#preop-prep"><i class="fa fa-check"></i><b>52.3</b> Preop Prep</a></li>
<li class="chapter" data-level="52.4" data-path="objectives---aprexent.html"><a href="objectives---aprexent.html#key-steps"><i class="fa fa-check"></i><b>52.4</b> Key Steps</a></li>
<li class="chapter" data-level="52.5" data-path="objectives---aprexent.html"><a href="objectives---aprexent.html#intraop-decisions"><i class="fa fa-check"></i><b>52.5</b> Intraop Decisions</a></li>
<li class="chapter" data-level="52.6" data-path="objectives---aprexent.html"><a href="objectives---aprexent.html#complications"><i class="fa fa-check"></i><b>52.6</b> Complications</a></li>
</ul></li>
<li class="chapter" data-level="53" data-path="rectal-cancer-staging.html"><a href="rectal-cancer-staging.html"><i class="fa fa-check"></i><b>53</b> Rectal Cancer Staging</a>
<ul>
<li class="chapter" data-level="53.1" data-path="rectal-cancer-staging.html"><a href="rectal-cancer-staging.html#mri-staging"><i class="fa fa-check"></i><b>53.1</b> MRI staging</a></li>
<li class="chapter" data-level="53.2" data-path="rectal-cancer-staging.html"><a href="rectal-cancer-staging.html#eus"><i class="fa fa-check"></i><b>53.2</b> EUS</a></li>
</ul></li>
<li class="chapter" data-level="54" data-path="rectal-ca-surgery.html"><a href="rectal-ca-surgery.html"><i class="fa fa-check"></i><b>54</b> Rectal Ca Surgery</a></li>
<li class="chapter" data-level="55" data-path="rectal-adjuvant-therapy.html"><a href="rectal-adjuvant-therapy.html"><i class="fa fa-check"></i><b>55</b> Rectal Adjuvant Therapy</a>
<ul>
<li class="chapter" data-level="55.1" data-path="rectal-adjuvant-therapy.html"><a href="rectal-adjuvant-therapy.html#surgery-rightarrow-crt"><i class="fa fa-check"></i><b>55.1</b> Surgery <span class="math inline">\(\Rightarrow\)</span> CRT</a></li>
<li class="chapter" data-level="55.2" data-path="rectal-adjuvant-therapy.html"><a href="rectal-adjuvant-therapy.html#crt-rightarrow-surgery"><i class="fa fa-check"></i><b>55.2</b> CRT <span class="math inline">\(\Rightarrow\)</span> Surgery</a></li>
<li class="chapter" data-level="55.3" data-path="rectal-adjuvant-therapy.html"><a href="rectal-adjuvant-therapy.html#short-course-rt"><i class="fa fa-check"></i><b>55.3</b> Short-course RT</a></li>
<li class="chapter" data-level="55.4" data-path="rectal-adjuvant-therapy.html"><a href="rectal-adjuvant-therapy.html#total-neoadjuvant"><i class="fa fa-check"></i><b>55.4</b> Total Neoadjuvant</a></li>
<li class="chapter" data-level="55.5" data-path="rectal-adjuvant-therapy.html"><a href="rectal-adjuvant-therapy.html#selective-adjuvant"><i class="fa fa-check"></i><b>55.5</b> Selective Adjuvant</a></li>
<li class="chapter" data-level="55.6" data-path="rectal-adjuvant-therapy.html"><a href="rectal-adjuvant-therapy.html#neoadjuvant-itx"><i class="fa fa-check"></i><b>55.6</b> Neoadjuvant ITx</a></li>
</ul></li>
<li class="chapter" data-level="56" data-path="neoadjuvant-chemotherapy-1.html"><a href="neoadjuvant-chemotherapy-1.html"><i class="fa fa-check"></i><b>56</b> Neoadjuvant Chemotherapy</a></li>
<li class="chapter" data-level="57" data-path="non-operative-management-of-rectal-cancer.html"><a href="non-operative-management-of-rectal-cancer.html"><i class="fa fa-check"></i><b>57</b> Non-operative management of Rectal Cancer</a></li>
<li class="chapter" data-level="58" data-path="anal-squamous-cell-carcinoma.html"><a href="anal-squamous-cell-carcinoma.html"><i class="fa fa-check"></i><b>58</b> Anal Squamous Cell Carcinoma</a>
<ul>
<li class="chapter" data-level="58.1" data-path="anal-squamous-cell-carcinoma.html"><a href="anal-squamous-cell-carcinoma.html#chemoradiation"><i class="fa fa-check"></i><b>58.1</b> Chemoradiation</a>
<ul>
<li class="chapter" data-level="58.1.1" data-path="anal-squamous-cell-carcinoma.html"><a href="anal-squamous-cell-carcinoma.html#restaging-after-chemort"><i class="fa fa-check"></i><b>58.1.1</b> Restaging after chemoRT</a></li>
</ul></li>
</ul></li>
<li class="part"><span><b>Sarcoma</b></span></li>
<li class="chapter" data-level="59" data-path="soft-tissue-sarcomas.html"><a href="soft-tissue-sarcomas.html"><i class="fa fa-check"></i><b>59</b> Soft Tissue Sarcomas</a>
<ul>
<li class="chapter" data-level="59.1" data-path="soft-tissue-sarcomas.html"><a href="soft-tissue-sarcomas.html#desmoid-tumors"><i class="fa fa-check"></i><b>59.1</b> Desmoid Tumors</a></li>
<li class="chapter" data-level="59.2" data-path="soft-tissue-sarcomas.html"><a href="soft-tissue-sarcomas.html#retroperitoneal"><i class="fa fa-check"></i><b>59.2</b> Retroperitoneal</a></li>
<li class="chapter" data-level="59.3" data-path="soft-tissue-sarcomas.html"><a href="soft-tissue-sarcomas.html#peritoneal-mesothelioma"><i class="fa fa-check"></i><b>59.3</b> Peritoneal mesothelioma</a></li>
</ul></li>
<li class="chapter" data-level="" data-path="references.html"><a href="references.html"><i class="fa fa-check"></i>References</a></li>
<li class="divider"></li>
<li><a href="mailto:jonathan.salo@atriumhealth.org">Feedback and Updates</a></li>

</ul>

      </nav>
    </div>

    <div class="book-body">
      <div class="body-inner">
        <div class="book-header" role="navigation">
          <h1>
            <i class="fa fa-circle-o-notch fa-spin"></i><a href="./">GI Surgical Oncology</a>
          </h1>
        </div>

        <div class="page-wrapper" tabindex="-1" role="main">
          <div class="page-inner">

            <section class="normal" id="section-">
<div id="locally_advanced" class="section level1 hasAnchor" number="30">
<h1><span class="header-section-number">30</span> Locally Advanced EsoCa<a href="locally_advanced.html#locally_advanced" class="anchor-section" aria-label="Anchor link to header"></a></h1>
<p>Tumors that are T2N<sup>+</sup>M0 or T3NxM0 are considered locally-advanced. The high rate of failure with surgery alone has led to development of adjunctive therapies.</p>
<div id="trimodality" class="section level2 hasAnchor" number="30.1">
<h2><span class="header-section-number">30.1</span> Trimodality Therapy<a href="locally_advanced.html#trimodality" class="anchor-section" aria-label="Anchor link to header"></a></h2>
<p>Trimodality therapy consists of chemoradiation followed by surgery.</p>
<p>CROSS trial randomized 364 patients with resectable esophageal and gastroesophageal junction tumors (75% adenocarcinoma) to neoadjuvant chemoradiation consisting of 4,140 cGy of radiation with concurrent carboplatin and paclitaxel or surgery alone.<span class="citation">(<a href="#ref-vanhagen2074">van Hagen et al. 2012</a>)</span> Clinical node-positive disease was present in 16%. Pathologic complete response was seen in 23% of adenocarcinoma and 49% of squamous cell carcinomas. Median overall survival was 49 months after trimodality vs 24 months after surgery alone (p=0.003). Squamous cell carcinomas appeared to have particular benefit, with a hazard ratio of 0.42 for squamous cell vs 0.74 for adenocarcinoma. Median survival was improved for adenocarcinoma from 27.1 months to 43.2 months, but the median survival for squamous cell increased from 27.1months to 81.6 months for squamous cell. Rate of R0 resection was higher with chemoradiation (92% vs 69% p&lt;0.001) andlocal recurrence rates lower (14% vs 34% P&lt;0.001), and peritoneal recurrence lower (4% vs 14% P&lt;0.001). Despite the relatively low dose of radiation, in-field recurrences were less than 5%. The primary cause of failure was distant disease (31%) and local/regional failure (14%).<span class="citation">(<a href="#ref-oppedijk385">Oppedijk et al. 2014</a>)</span></p>
<p>Alternative to carbotaxol is FOLFOX (SOG trial <span class="citation">(<a href="#ref-leichman4555">Leichman et al. 2011</a>)</span>)</p>
<p>Ongoing PROTECT trial compares FOLFOX to paclitaxel and carboplatin <span class="citation">(<a href="#ref-messager318">Messager et al. 2016</a>)</span></p>
<p>See also <a href="eso_dcrt.html#eso_dcrt">Definitive ChemoRT</a></p>
<div id="neoadjuvant-chemort-for-scca" class="section level3 hasAnchor" number="30.1.1">
<h3><span class="header-section-number">30.1.1</span> Neoadjuvant chemoRT for SCCA<a href="locally_advanced.html#neoadjuvant-chemort-for-scca" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<p>NeoCRTEC5010 <span class="citation">(<a href="#ref-yang2796">Yang et al. 2018</a>)</span> <!--- JCO 2018 ---></p>
<p>Meta-abalysis of chemoRT vs chemo <span class="citation">(<a href="#ref-zhaoe0202185">Zhao et al. 2018</a>)</span></p>
</div>
<div id="neoadjuvant-chemotheraphy-followed-by-surgery" class="section level3 hasAnchor" number="30.1.2">
<h3><span class="header-section-number">30.1.2</span> Neoadjuvant chemotheraphy followed by surgery<a href="locally_advanced.html#neoadjuvant-chemotheraphy-followed-by-surgery" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<p>POET Trial (Pre-Operative therapy in Esophageal adenocarcinoma Trial) treated patients with adenocarcinoma of the gastroesophageal junction with either neoadjuvant chemotherapy (5-FU, leucovorin, cisplatin) followed by surgery or induction chemotherapy with the same agents, followed by chemoradiation (4000cGy with concurrent cisplatin and etoposide). The study failed to meet its accrual goal, but there was a suggestion of improved 3-year survival with preoperative chemoradiation (47.4% vs 27.7% <em>p</em>=0.07) as well as improved local control (76.5% vs 59%). In addition, chemoradiation was associated with a higher pathologic complete response rate (15.6% vs 2%)<span class="citation">(<a href="#ref-stahl851">Stahl et al. 2009</a>)</span>. A meta-analysis of 33 randomized trials further suggested a greater benefit from neoadjuvant chemoradiation followed by surgery compared with neoadjuvant chemotherapy followed by surgery<span class="citation">(<a href="#ref-pasquali481">Pasquali et al. 2017</a>)</span> and a similar meta-analysis <span class="citation">(<a href="#ref-sjoquist681">Sjoquist et al. 2011</a>)</span></p>
<p>#Active Surveillance</p>
<p>EGD is poor predictor of pCR <span class="citation">(<a href="#ref-sarkaria764"><strong>sarkaria764?</strong></a>)</span></p>
</div>
</div>
<div id="ge-junction" class="section level2 hasAnchor" number="30.2">
<h2><span class="header-section-number">30.2</span> GE Junction<a href="locally_advanced.html#ge-junction" class="anchor-section" aria-label="Anchor link to header"></a></h2>
<p><span class="citation">(<a href="#ref-siewert260">Siewert, Stein, and Feith 2006</a>)</span></p>
</div>
<div id="induction-chemotherapy-followed-by-chemort" class="section level2 hasAnchor" number="30.3">
<h2><span class="header-section-number">30.3</span> Induction chemotherapy followed by chemoRT<a href="locally_advanced.html#induction-chemotherapy-followed-by-chemort" class="anchor-section" aria-label="Anchor link to header"></a></h2>
<p>See NCCN pages M-25 and M-26</p>
<p>Stahl <span class="citation">(<a href="#ref-stahl851">Stahl et al. 2009</a>)</span> randomized patients to preoperative chemotherapy (A) vs preoperative chemotherapy followed by preoperative chemoradiation (B). Higher pcR rate in arm B (15.6% vs 2%) and ypN0 resection (64.4% vs 37.7%).</p>
</div>
<div id="postoperative-chemoradiation" class="section level2 hasAnchor" number="30.4">
<h2><span class="header-section-number">30.4</span> Postoperative chemoradiation<a href="locally_advanced.html#postoperative-chemoradiation" class="anchor-section" aria-label="Anchor link to header"></a></h2>
<p>Intergroup-0116 <span class="citation">(<a href="#ref-macdonald725">Macdonald et al. 2001</a>)</span> <span class="citation">(<a href="#ref-smalley2327">Smalley et al. 2012</a>)</span> treated 556 patients with adenocarcinoma of the stomach or GE junction with surgery along vs surgery followed by postoperative chemoradiation. After a median followup of over 5 years, median overall survival iin the surgery alone group was 27 months vs 36 months in the postoperative chemoradiation group (p=0.005) Decrease in local failure as the first site of failure in the chemoradiation group (19% versus 29%).</p>
<p>Chemoradiation afte resectdion of GE junction tumors <span class="citation">(<a href="#ref-kofoed26">Kofoed et al. 2012</a>)</span> among a group of 211 patients with GE junction adenocarcinoma with positive lymph nodes with improved 3-year disease-free survival (37% s 24%).</p>

</div>
</div>
<h3>References</h3>
<div id="refs" class="references csl-bib-body hanging-indent">
<div id="ref-kofoed26" class="csl-entry">
Kofoed, S. C., A. Muhic, L. Baeksgaard, M. Jendresen, J. Gustafsen, J. Holm, L. Bardram, B. Brandt, J. Brenø, and L. B. Svendsen. 2012. <span>“Survival After Adjuvant Chemoradiotherapy or Surgery Alone in Resectable Adenocarcinoma at the Gastro-Esophageal Junction.”</span> <em>Scandinavian Journal of Surgery: SJS: Official Organ for the Finnish Surgical Society and the Scandinavian Surgical Society</em> 101 (1): 26–31. <a href="https://doi.org/10.1177/145749691210100106">https://doi.org/10.1177/145749691210100106</a>.
</div>
<div id="ref-leichman4555" class="csl-entry">
Leichman, Lawrence P., Bryan H. Goldman, Pierre O. Bohanes, Heinz J. Lenz, Charles R. Thomas, Kevin G. Billingsley, Christopher L. Corless, et al. 2011. <span>“S0356: A Phase <span>II</span> Clinical and Prospective Molecular Trial with Oxaliplatin, Fluorouracil, and External-Beam Radiation Therapy Before Surgery for Patients with Esophageal Adenocarcinoma.”</span> <em>Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology</em> 29 (34): 4555–60. <a href="https://doi.org/10.1200/JCO.2011.36.7490">https://doi.org/10.1200/JCO.2011.36.7490</a>.
</div>
<div id="ref-macdonald725" class="csl-entry">
Macdonald, J. S., S. R. Smalley, J. Benedetti, S. A. Hundahl, N. C. Estes, G. N. Stemmermann, D. G. Haller, et al. 2001. <span>“Chemoradiotherapy After Surgery Compared with Surgery Alone for Adenocarcinoma of the Stomach or Gastroesophageal Junction.”</span> <em>The New England Journal of Medicine</em> 345 (10): 725–30. <a href="https://doi.org/10.1056/NEJMoa010187">https://doi.org/10.1056/NEJMoa010187</a>.
</div>
<div id="ref-messager318" class="csl-entry">
Messager, Mathieu, Xavier Mirabel, Emmanuelle Tresch, Amaury Paumier, Véronique Vendrely, Laetitia Dahan, Olivier Glehen, et al. 2016. <span>“Preoperative Chemoradiation with Paclitaxel-Carboplatin or with Fluorouracil-Oxaliplatin-Folinic Acid (<span>FOLFOX</span>) for Resectable Esophageal and Junctional Cancer: The <span>PROTECT-1402</span>, Randomized Phase 2 Trial.”</span> <em>BMC Cancer</em> 16 (May): 318. <a href="https://doi.org/10.1186/s12885-016-2335-9">https://doi.org/10.1186/s12885-016-2335-9</a>.
</div>
<div id="ref-oppedijk385" class="csl-entry">
Oppedijk, Vera, Ate van der Gaast, Jan J. B. van Lanschot, Pieter van Hagen, Rob van Os, Caroline M. van Rij, Maurice J. van der Sangen, et al. 2014. <span>“Patterns of Recurrence After Surgery Alone Versus Preoperative Chemoradiotherapy and Surgery in the <span>CROSS</span> Trials.”</span> <em>Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology</em> 32 (5): 385–91. <a href="https://doi.org/10.1200/JCO.2013.51.2186">https://doi.org/10.1200/JCO.2013.51.2186</a>.
</div>
<div id="ref-pasquali481" class="csl-entry">
Pasquali, Sandro, Guang Yim, Ravinder S. Vohra, Simone Mocellin, Donald Nyanhongo, Paul Marriott, Ju Ian Geh, and Ewen A. Griffiths. 2017. <span>“Survival <span>After Neoadjuvant</span> and <span>Adjuvant Treatments Compared</span> to <span>Surgery Alone</span> for <span>Resectable Esophageal Carcinoma</span>: <span class="nocase">A Network Meta-analysis</span>.”</span> <em>Annals of Surgery</em> 265 (3): 481–91. <a href="https://doi.org/10.1097/SLA.0000000000001905">https://doi.org/10.1097/SLA.0000000000001905</a>.
</div>
<div id="ref-siewert260" class="csl-entry">
Siewert, J. R., H. J. Stein, and M. Feith. 2006. <span>“Adenocarcinoma of the Esophago-Gastric Junction.”</span> <em>Scandinavian Journal of Surgery: SJS: Official Organ for the Finnish Surgical Society and the Scandinavian Surgical Society</em> 95 (4): 260–69. <a href="https://doi.org/10.1177/145749690609500409">https://doi.org/10.1177/145749690609500409</a>.
</div>
<div id="ref-sjoquist681" class="csl-entry">
Sjoquist, Katrin M., Bryan H. Burmeister, B. Mark Smithers, John R. Zalcberg, R. John Simes, Andrew Barbour, Val Gebski, and Australasian Gastro-Intestinal Trials Group. 2011. <span>“Survival After Neoadjuvant Chemotherapy or Chemoradiotherapy for Resectable Oesophageal Carcinoma: An Updated Meta-Analysis.”</span> <em>The Lancet. Oncology</em> 12 (7): 681–92. <a href="https://doi.org/10.1016/S1470-2045(11)70142-5">https://doi.org/10.1016/S1470-2045(11)70142-5</a>.
</div>
<div id="ref-smalley2327" class="csl-entry">
Smalley, Stephen R., Jacqueline K. Benedetti, Daniel G. Haller, Scott A. Hundahl, Norman C. Estes, Jaffer A. Ajani, Leonard L. Gunderson, et al. 2012. <span>“Updated Analysis of <span class="nocase">SWOG-directed</span> Intergroup Study 0116: A Phase <span>III</span> Trial of Adjuvant Radiochemotherapy Versus Observation After Curative Gastric Cancer Resection.”</span> <em>Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology</em> 30 (19): 2327–33. <a href="https://doi.org/10.1200/JCO.2011.36.7136">https://doi.org/10.1200/JCO.2011.36.7136</a>.
</div>
<div id="ref-stahl851" class="csl-entry">
Stahl, Michael, Martin K. Walz, Martin Stuschke, Nils Lehmann, Hans-Joachim Meyer, Jorge Riera-Knorrenschild, Peter Langer, et al. 2009. <span>“Phase <span>III</span> Comparison of Preoperative Chemotherapy Compared with Chemoradiotherapy in Patients with Locally Advanced Adenocarcinoma of the Esophagogastric Junction.”</span> <em>Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology</em> 27 (6): 851–56. <a href="https://doi.org/10.1200/JCO.2008.17.0506">https://doi.org/10.1200/JCO.2008.17.0506</a>.
</div>
<div id="ref-vanhagen2074" class="csl-entry">
van Hagen, P., M. C. C. M. Hulshof, J. J. B. van Lanschot, E. W. Steyerberg, M. I. van Berge Henegouwen, B. P. L. Wijnhoven, D. J. Richel, et al. 2012. <span>“Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer.”</span> <em>The New England Journal of Medicine</em> 366 (22): 2074–84. <a href="https://doi.org/10.1056/NEJMoa1112088">https://doi.org/10.1056/NEJMoa1112088</a>.
</div>
<div id="ref-yang2796" class="csl-entry">
Yang, Hong, Hui Liu, Yuping Chen, Chengchu Zhu, Wentao Fang, Zhentao Yu, Weimin Mao, et al. 2018. <span>“Neoadjuvant <span>Chemoradiotherapy Followed</span> by <span>Surgery Versus Surgery Alone</span> for <span>Locally Advanced Squamous Cell Carcinoma</span> of the <span>Esophagus</span> (<span>NEOCRTEC5010</span>): <span>A Phase III Multicenter</span>, <span>Randomized</span>, <span>Open-Label Clinical Trial</span>.”</span> <em>Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology</em> 36 (27): 2796–2803. <a href="https://doi.org/10.1200/JCO.2018.79.1483">https://doi.org/10.1200/JCO.2018.79.1483</a>.
</div>
<div id="ref-zhaoe0202185" class="csl-entry">
Zhao, Xin, Yiming Ren, Yong Hu, Naiqiang Cui, Ximo Wang, and Yunfeng Cui. 2018. <span>“Neoadjuvant Chemotherapy Versus Neoadjuvant Chemoradiotherapy for Cancer of the Esophagus or the Gastroesophageal Junction: <span>A</span> Meta-Analysis Based on Clinical Trials.”</span> <em>PloS One</em> 13 (8): e0202185. <a href="https://doi.org/10.1371/journal.pone.0202185">https://doi.org/10.1371/journal.pone.0202185</a>.
</div>
</div>
            </section>

          </div>
        </div>
      </div>
<a href="localized.html" class="navigation navigation-prev " aria-label="Previous page"><i class="fa fa-angle-left"></i></a>
<a href="eso_dcrt.html" class="navigation navigation-next " aria-label="Next page"><i class="fa fa-angle-right"></i></a>
    </div>
  </div>
<script src="libs/gitbook-2.6.7/js/app.min.js"></script>
<script src="libs/gitbook-2.6.7/js/clipboard.min.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-search.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-sharing.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-fontsettings.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-bookdown.js"></script>
<script src="libs/gitbook-2.6.7/js/jquery.highlight.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-clipboard.js"></script>
<script>
gitbook.require(["gitbook"], function(gitbook) {
gitbook.start({
"sharing": {
"github": false,
"facebook": true,
"twitter": true,
"linkedin": false,
"weibo": false,
"instapaper": false,
"vk": false,
"whatsapp": false,
"all": ["facebook", "twitter", "linkedin", "weibo", "instapaper"]
},
"fontsettings": {
"theme": "white",
"family": "sans",
"size": 2
},
"edit": {
"link": "https://github.com/jcsalo/gi_surgonc/edit/main/537-eso_t3.Rmd",
"text": "Edit"
},
"history": {
"link": null,
"text": null
},
"view": {
"link": null,
"text": null
},
"download": ["gi_surgonc.pdf", "gi_surgonc.epub"],
"search": {
"engine": "fuse",
"options": null
},
"toc": {
"collapse": "section",
"scroll_highlight": true,
"search": true,
"sharing": false
}
});
});
</script>

<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    var src = "true";
    if (src === "" || src === "true") src = "https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.9/latest.js?config=TeX-MML-AM_CHTML";
    if (location.protocol !== "file:")
      if (/^https?:/.test(src))
        src = src.replace(/^https?:/, '');
    script.src = src;
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>
</body>

</html>
